Picture of Kamada logo

KMDA — Kamada News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedSmall CapSuper Stock

Brief: Kamada Reports Financial Results For Fourth Quarter And FY2018

Feb 12 (Reuters) - Kamada Ltd  KMDA.TA :
    * KAMADA REPORTS FINANCIAL RESULTS FOR FOURTH QUARTER AND
FISCAL
YEAR 2018
    * Q4 EARNINGS PER SHARE $0.44
    * Q4 REVENUE ROSE 35 PERCENT TO $48.2 MILLION
    * SEES FY 2019 REVENUE $125 MILLION TO $130 MILLION
    * REITERATING FULL-YEAR 2019 TOTAL REVENUE GUIDANCE OF $125
MILLION TO $130 MILLION
    * PENDING FDA CLEARANCE OF REQUESTED INFORMATION, CO INTENDS
TO
INITIATE A PHASE 3 CLINICAL TRIAL OF INHALED AAT DURING 2019
    * TOP-LINE DATA FROM PHASE 2 TRIAL OF IV-AAT IS EXPECTED BY
END OF
2019

Source text for Eikon:  ID:nGNX5K8Ms2 
Further company coverage:  KMDA.TA 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Kamada

See all news